Advertisement
Advertisement

MANE

MANE logo

Veradermics, Incorporated

114.39
USD
Sponsored
+5.74
+5.28%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

114.37

-0.02
-0.02%

Veradermics, Incorporated Profile

About

Veradermics Incorporated is a late clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment in prevalent aesthetic and dermatological conditions. Veradermics Incorporated is based in NEW HAVEN, Conn.

Info & Links

CEO

Reid Waldman

Headquarters

470 JAMES STREET
NEW HAVEN, CT 06513, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.veradermics.com

Auditor

Deloitte & Touche LLP

Share holders

--

Employees

21

Veradermics, Incorporated Statistics

Valuation Measures

Market Capitalization2

4.78B

Enterprise Value

4.61B

Enterprise Value/EBITDA(ttm)

-154.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

10.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-6.97%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.86M

Net Income Available to Common(ttm)

-30.01M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

41.78M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

390.80M

Total Cash Per Share(mrq)

9.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

59.12%

Quick Ratio(mrq)

59.12%

Book Value Per Share(mrq)

10.46

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.93

Free Cash Flow(ytd)

-21.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement